Vitamin K2 has been called "the forgotten vitamin" — it's distinct from the more well-known vitamin K1, works through different mechanisms in the body, and has an emerging evidence base suggesting important roles in bone health, cardiovascular health, and possibly dental and cognitive health. Despite these findings, many healthcare providers and patients conflate K1 and K2 as if they're interchangeable. They're not — and understanding the difference may genuinely matter for your health.

Vitamin K1 vs. K2: Fundamentally Different Roles

Vitamin K1 (phylloquinone) is found predominantly in dark leafy greens — spinach, kale, broccoli, Brussels sprouts. It's primarily involved in blood clotting — activating clotting factors in the liver. This is the form most people encounter when told to maintain consistent "vitamin K" intake on blood thinners like warfarin.

Vitamin K2 (menaquinone) is found in fermented foods and animal products. Unlike K1, it circulates in the body for much longer and reaches tissues beyond the liver — particularly bone, arterial walls, and other soft tissues. Its primary role involves activating K2-dependent proteins that regulate calcium metabolism throughout the body, directing calcium into bones and teeth while potentially helping prevent it from accumulating in arterial walls and soft tissues where it doesn't belong.

The Forms of Vitamin K2

Vitamin K2 itself comes in multiple forms called menaquinones (MK), numbered by the length of their side chain:

How Vitamin K2 Works: The Calcium Connection

The key mechanism involves two K2-dependent proteins:

This dual role — supporting calcium's deposition in bones while potentially inhibiting its deposition in arteries — is what makes K2 theoretically attractive for both bone and cardiovascular health.

Evidence for Health Benefits

Bone Health

Several RCTs and large population studies support K2's role in bone health:

Cardiovascular Health

The Rotterdam Study — a large Dutch cohort following over 4,800 participants — found that the highest dietary K2 intake was associated with a 57% lower risk of cardiovascular death and significantly less aortic calcification compared to the lowest intake. Crucially, dietary K1 showed no such association — suggesting this is specifically a K2 effect. MGP, activated by K2, is the key protein proposed to inhibit vascular calcification in this context.

Randomized trials with K2 supplementation show reductions in arterial stiffness in specific populations (kidney disease, healthy postmenopausal women), and reductions in dp-ucMGP (a marker of MGP inactivation and thus K2 insufficiency) with supplementation.

Dental Health

Vitamin K2 activates a protein called osteocalcin in the teeth (analogous to its bone role), which some research and Weston Price's historical anthropological work suggests may be involved in dental health and resistance to decay. This area has less rigorous RCT evidence than bone and cardiovascular effects but remains an active research interest.

Best Food Sources of K2

FoodK2 ContentPrimary Form
Natto (fermented soybeans)~900–1000 mcg/100gMK-7 (by far the richest source)
Gouda cheese~75 mcg/100gMK-8, MK-9
Brie/Edam cheese~50–60 mcg/100gMK-8, MK-9
Egg yolk~15–30 mcg/100gMK-4
Chicken breast/leg (dark meat higher)~10–35 mcg/100gMK-4
Butter (grass-fed higher)~10–15 mcg/100gMK-4
Beef liver~11 mcg/100gMK-4

Natto's K2 content is extraordinary — a single 100g serving provides roughly the entire amount shown to benefit bone health in supplementation studies. It's an acquired taste that many Westerners find challenging, but it's the most nutritionally dense K2 food by a significant margin.

Supplementation

Typical supplemental doses of K2 range from 100–200 mcg of MK-7 daily — this is the form and dose range most studied in recent bone and cardiovascular RCTs. MK-7 is preferred over MK-4 in supplements because its long half-life means once-daily dosing maintains stable circulating levels, whereas MK-4's rapid clearance requires much higher doses (pharmacological 45mg in Japanese studies, not achievable with standard supplements) to see similar effects.

K2 supplements are fat-soluble — take with a meal containing dietary fat for optimal absorption. K2 is often combined with vitamin D3 in supplements since both are important for calcium metabolism and may work synergistically — vitamin D promotes calcium absorption while K2 influences where calcium goes once absorbed.

Safety and Drug Interactions

Vitamin K2 at typical supplemental doses (100–200 mcg MK-7) is considered safe for most people. The main drug interaction concern is with warfarin (coumadin) — vitamin K (including K2) antagonizes warfarin's blood-thinning action. People on warfarin should not change their vitamin K intake significantly without medical supervision and INR monitoring. Newer oral anticoagulants (apixaban, rivaroxaban, dabigatran) are not vitamin K-dependent and don't interact with dietary K2 in the same way — though always confirm with your prescribing physician.

Frequently Asked Questions

Q: Do I need to take K2 alongside vitamin D3?
Many practitioners and researchers recommend this combination because both nutrients are involved in calcium metabolism and may work synergistically: vitamin D increases calcium absorption from the gut, and K2 activates proteins that direct that absorbed calcium appropriately (into bones rather than soft tissues). The concern that high-dose vitamin D without adequate K2 might promote inappropriate calcium deposition hasn't been definitively proven in humans, but the biological rationale is plausible. Combining them is a reasonable precaution, particularly if taking supplemental vitamin D3 above 2,000 IU daily.
Q: Is K2 the same as the vitamin K2 in multivitamins?
Many multivitamins include only vitamin K1 (phylloquinone), not K2. Some include small amounts of K2 (often 10–45 mcg MK-7), and some premium multivitamins include meaningful K2 doses. Check the supplement facts label specifically for menaquinone or MK-7 to see if and how much K2 your multivitamin provides. Standard multivitamins listing "Vitamin K" without specifying the form typically contain only K1.
Q: Does grass-fed butter really have more K2?
Yes — butter from grass-fed cows contains significantly more vitamin K2 (MK-4) than butter from grain-fed cows, since the cows convert dietary plant K1 from grass to K2. Studies have found 2–5 fold higher K2 content in grass-fed dairy compared to conventionally raised dairy. This is consistent with the general principle that pasture-raised, grass-fed animal products tend to have more favorable fat-soluble vitamin profiles. While the absolute amounts of K2 in butter are modest compared to natto or aged cheese, this nutritional advantage of grass-fed dairy is real.
Q: Can vitamin K2 reverse existing arterial calcification?
Current evidence doesn't convincingly demonstrate that K2 supplementation reverses established arterial calcification, though some animal studies and one small human trial (the VitaK-CAC trial) showed some slowing of progression rather than reversal. The strongest evidence is for K2 potentially slowing or preventing the progression of calcification rather than reversing existing deposits. Given how early this research area is in humans, thinking of K2 as potentially preventive for arterial calcification rather than as a treatment for existing disease is the most accurate framing of current evidence.
Q: How do I know if I'm K2-deficient?
There's no simple, widely available blood test that specifically identifies K2 status. The most relevant marker is dp-ucMGP (desphospho-uncarboxylated Matrix Gla Protein) — elevated levels indicate insufficient K2 activation of MGP, suggesting K2 insufficiency. This test is available in research settings and from some specialized labs but isn't routine clinical practice. Practically, if your diet contains little fermented food and limited dairy and eggs, your K2 intake is likely below optimal levels regardless of K1 status — dietary assessment is the most accessible practical approach.
References:
1. Geleijnse JM et al. "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease." Journal of Nutrition. 2004 (Rotterdam Study). academic.oup.com/jn
2. Knapen MHJ et al. "Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women." Osteoporosis International. 2013.
3. Maresz K. "Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health." Integrative Medicine. 2015.
4. NIH Office of Dietary Supplements. "Vitamin K Fact Sheet." 2024. ods.od.nih.gov